This HEDIS measure assesses women 50–74 years of age who had at least one mammogram to screen for breast cancer in the past two years.
The Breast Cancer Screening measure is also available in an ECDS format. Please visit ECDS webpage and NCQA Store for more information.
Why It Matters
Aside from some forms of skin cancer, breast cancer is the most common cancer among American women, regardless of race or ethnicity.1 Screening can improve outcomes: Early detection reduces the risk of dying from breast cancer and can lead to a greater range of treatment options and lower health care costs.2
Results – National Averages
Breast Cancer Screening Rate
|Measure Year||Commerical HMO||Commercial PPO||Medicaid HMO||Medicare HMO||Medicare PPO|
§ Not available due to CMS suspension of data reporting during COVID-19 pandemic.
This State of Healthcare Quality Report classifies health plans differently than NCQA’s Quality Compass. HMO corresponds to All LOBs (excluding PPO and EPO) within Quality Compass. PPO corresponds to PPO and EPO within Quality Compass.
Figures do not account for changes in the underlying measure that could break trending. Contact Information Products via my.ncqa.org for analysis that accounts for trend breaks.
- Centers for Disease Control and Prevention (CDC). 2018. “Breast Cancer Statistics.” http://www.cdc.gov/cancer/breast/statistics/index.htm
- American Cancer Society. 2017. “American Cancer Society Recommendations for the Early Detection of Breast Cancer.” https://www.cancer.org/cancer/breast-cancer/screening-tests-and-early-detection/american-cancer-society-recommendations-for-the-early-detection-of-breast-cancer.html